AI-Based Stool Image Analysis for Colorectal Neoplasia Risk Assessment (FECAL-AI)
28 de julho de 2026 atualizado por: Servicio de Salud Metropolitano Sur Oriente
FECAL-AI: Prospective Observational Validation of AI-Based Stool Image Analysis Against Quantitative Fecal Immunochemical Testing for Colorectal Neoplasia Risk Assessment
This prospective observational substudy evaluates the association between artificial intelligence-derived features from stool images analyzed using the FAEX Health digital platform and fecal immunochemical test results in adults undergoing colorectal cancer screening or diagnostic evaluation.
Participants will capture stool images using a mobile application.
The primary analysis will compare AI-derived image outputs with quantitative FIT values and FIT positivity.
Secondary exploratory analyses will assess associations with colonoscopy and histopathological findings when these results are available.
The platform will be used exclusively for research and will not provide diagnoses, replace clinical evaluation, or influence medical decisions.
Visão geral do estudo
Status
Recrutamento
Condições
Intervenção / Tratamento
Descrição detalhada
This is a substudy of the project "Estrategia de prevención secundaria de cáncer colorrectal en personas mayores a 18 años." The substudy evaluates the FAEX Health digital platform, which applies artificial intelligence algorithms to stool images for non-diagnostic research and validation.
Participants will capture images of their stools using the FAEX Health mobile application. The images will be coded and analyzed using computational algorithms designed to identify visual characteristics such as color, consistency, and possible visible blood.
The primary objective is to evaluate the association and discriminatory performance of AI-derived stool image features for quantitative fecal immunochemical test results and FIT positivity. Secondary exploratory objectives are to assess associations between these image features and colonoscopic and histopathological findings among participants for whom these results are available.
The AI-derived results will not be returned to participants or treating clinicians and will not be used to determine whether colonoscopy or any other clinical procedure is performed. The findings may inform future studies evaluating stool image analysis as a potential triage strategy when FIT is unavailable or declined; however, the present study does not evaluate the platform as a replacement for FIT.
Personal identifiers will not be stored together with stool images. Access to coded study information will be restricted to authorized researchers, and study data will be managed according to applicable ethical, legal, and confidentiality requirements.
Tipo de estudo
Observacional
Inscrição (Estimado)
250
Contactos e Locais
Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.
Contato de estudo
- Nome: Erik Manriquez Alegria, MD
- Número de telefone: +56988232111
- E-mail: erik.manriquez.alegria@gmail.com
Estude backup de contato
- Nome: Felipe Quezada Diaz, MD
- Número de telefone: +56934651992
- E-mail: ffquezad@gmail.com
Locais de estudo
-
-
Santiago Metropolitan
-
Santiago, Santiago Metropolitan, Chile, 8207257
- Recrutamento
- Hospital Sotero Del Rio
-
Contato:
- Erik Manriquez Alegria, MD
- Número de telefone: +56988232111
- E-mail: erik.manriquez.alegria@gmail.com
-
Contato:
- Felipe Quezada Diaz, MD
- Número de telefone: +56934651992
- E-mail: ffquezad@gmail.com
-
-
Critérios de participação
Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.
Critérios de elegibilidade
Idades elegíveis para estudo
- Adulto
- Adulto mais velho
Aceita Voluntários Saudáveis
N/D
Método de amostragem
Amostra Não Probabilística
População do estudo
Adults receiving care at Hospital Dr. Sótero del Río who are undergoing colorectal cancer screening or diagnostic evaluation and have a quantitative fecal immunochemical test planned or completed.
Eligible participants will prospectively submit stool images through the FAEX Health mobile application.
AI-derived image features will be compared primarily with matched quantitative FIT results and FIT positivity.
Colonoscopy and histopathology findings will be evaluated as secondary exploratory outcomes when available.
AI results will not be returned to participants or clinicians and will not influence clinical management.
Descrição
Inclusion Criteria:
- Age 18 years or older.
- Referred for screening or diagnostic colonoscopy at Hospital Dr. Sótero del Río.
- Quantitative fecal immunochemical testing planned or completed within 30 days before or after stool image submission.
- Able to submit at least one stool image using the FAEX Health mobile application, independently or with assistance.
- Able and willing to provide written informed consent.
Exclusion Criteria:
- Unable or unwilling to provide written informed consent.
- Previous enrollment in the study.
- Unable to complete stool-image capture, even with assistance.
- Study images and clinical data cannot be reliably linked using the assigned study code.
Plano de estudo
Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.
Como o estudo é projetado?
Detalhes do projeto
Coortes e Intervenções
Grupo / Coorte |
Intervenção / Tratamento |
|---|---|
|
Prospective Stool Image, FIT and Colonoscopy Cohort
Adults participating in colorectal cancer screening or diagnostic evaluation who submit stool images through the FAEX Health mobile application.
AI-derived stool image outputs will be compared primarily with quantitative fecal immunochemical test results and FIT positivity.
Colonoscopy and histopathology findings will be evaluated as secondary exploratory outcomes when available.
AI-derived results will not be returned to participants or clinicians and will not influence clinical decisions.
|
Participants capture stool images using the FAEX Health mobile application.
Coded images are analyzed using artificial intelligence algorithms to derive visual features and a prespecified patient-level output or score.
The AI-derived output is used exclusively for research and is compared primarily with quantitative FIT results and FIT positivity, with secondary comparisons against colonoscopy and histopathology when available.
The output is not used to provide a diagnosis or guide clinical management.
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Correlation Between AI-Derived Stool Image Score and Quantitative FIT (faecal immunochemical test) Concentration
Prazo: Within 90 days of stool image submission
|
Correlation coefficient between the prespecified patient-level AI-derived stool image score and quantitative fecal immunochemical test concentration among participants with analyzable matched data, reported with a 95% confidence interval.
|
Within 90 days of stool image submission
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Area Under the ROC Curve for FIT Positivity
Prazo: Within 90 days of stool image submission
|
Area under the receiver operating characteristic curve of the prespecified AI-derived stool image score for classifying participants as FIT positive or FIT negative according to the locally established FIT threshold, reported with a 95% confidence interval.
|
Within 90 days of stool image submission
|
|
Sensitivity and Specificity of the AI-Derived Stool Image Score for FIT Positivity/Negativity
Prazo: Within 90 days of stool image submission
|
Sensitivity and Specificity of a prespecified AI-derived stool image score threshold for identifying participants with a positive/negative FIT result, reported as a percentage with a 95% confidence interval.
|
Within 90 days of stool image submission
|
|
Area Under the ROC Curve for Colonoscopy-Detected Colorectal Neoplasia
Prazo: Within 90 days of stool image submission
|
Area under the receiver operating characteristic curve of the AI-derived stool image score for identifying colorectal neoplasia detected at colonoscopy, with histopathological confirmation when available.
|
Within 90 days of stool image submission
|
Colaboradores e Investigadores
É aqui que você encontrará pessoas e organizações envolvidas com este estudo.
Patrocinador
Investigadores
- Investigador principal: Erik Manriquez Alegria, MD, Hospital Sotero Del Rio
Publicações e links úteis
A pessoa responsável por inserir informações sobre o estudo fornece voluntariamente essas publicações. Estes podem ser sobre qualquer coisa relacionada ao estudo.
Publicações Gerais
- Collins GS, Moons KGM, Dhiman P, Riley RD, Beam AL, Van Calster B, Ghassemi M, Liu X, Reitsma JB, van Smeden M, Boulesteix AL, Camaradou JC, Celi LA, Denaxas S, Denniston AK, Glocker B, Golub RM, Harvey H, Heinze G, Hoffman MM, Kengne AP, Lam E, Lee N, Loder EW, Maier-Hein L, Mateen BA, McCradden MD, Oakden-Rayner L, Ordish J, Parnell R, Rose S, Singh K, Wynants L, Logullo P. TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods. BMJ. 2024 Apr 16;385:e078378. doi: 10.1136/bmj-2023-078378.
- Lee JW, Woo D, Kim KO, Kim ES, Kim SK, Lee HS, Kang B, Lee YJ, Kim J, Jang BI, Kim EY, Jo HH, Chung YJ, Ryu H, Park SK, Park DI, Yu H, Jeong S; IBD Research Group of KASID and Crohn's and Colitis Association in Daegu-Gyeongbuk (CCAiD). Deep Learning Model Using Stool Pictures for Predicting Endoscopic Mucosal Inflammation in Patients With Ulcerative Colitis. Am J Gastroenterol. 2025 Jan 1;120(1):213-224. doi: 10.14309/ajg.0000000000002978. Epub 2024 Jul 25.
- Sounderajah V, Guni A, Liu X, Collins GS, Karthikesalingam A, Markar SR, Golub RM, Denniston AK, Shetty S, Moher D, Bossuyt PM, Darzi A, Ashrafian H; STARD-AI Steering Committee. The STARD-AI reporting guideline for diagnostic accuracy studies using artificial intelligence. Nat Med. 2025 Oct;31(10):3283-3289. doi: 10.1038/s41591-025-03953-8. Epub 2025 Sep 15.
- Zhong H, Hou C, Huang Z, Chen X, Zou Y, Zhang H, Wang T, Wang L, Huang X, Xiang Y, Zhong M, Hu M, Xiong D, Wang L, Zhang Y, Luo Y, Guan Y, Xia M, Liu X, Yang J, Gan T, Wei W, Chen H, Gong H. A clinical pilot trial of an artificial intelligence-driven smart phone application of bowel preparation for colonoscopy: a randomized clinical trial. Scand J Gastroenterol. 2025 Jan;60(1):116-121. doi: 10.1080/00365521.2024.2443520. Epub 2024 Dec 22.
- Ramprasad C, Saini D, Del Carmen H, Krasnovsky L, Chandra R, Mcgregor R, Shinohara RT, Eaton E, Gummadi M, Mehta S, Lewis JD. Text Message System for the Prediction of Colonoscopy Bowel Preparation Adequacy Before Colonoscopy: An Artificial Intelligence Image Classification Algorithm Based on Images of Stool Output. Gastro Hep Adv. 2024 Sep 19;4(2):100556. doi: 10.1016/j.gastha.2024.09.011. eCollection 2025.
- Katsoula A, Paschos P, Haidich AB, Tsapas A, Giouleme O. Diagnostic Accuracy of Fecal Immunochemical Test in Patients at Increased Risk for Colorectal Cancer: A Meta-analysis. JAMA Intern Med. 2017 Aug 1;177(8):1110-1118. doi: 10.1001/jamainternmed.2017.2309.
- Rahman F, Trivedy M, Rao C, Akinlade F, Mansuri A, Aggarwal A, Laskaratos FM, Rajendran N, Banerjee S. Faecal Immunochemical Testing to Detect Colorectal Cancer in Symptomatic Patients: A Diagnostic Accuracy Study. Diagnostics (Basel). 2023 Jul 10;13(14):2332. doi: 10.3390/diagnostics13142332.
- Bailey JA, Weller J, Chapman CJ, Ford A, Hardy K, Oliver S, Morling JR, Simpson JA, Humes DJ, Banerjea A. Faecal immunochemical testing and blood tests for prioritization of urgent colorectal cancer referrals in symptomatic patients: a 2-year evaluation. BJS Open. 2021 Mar 5;5(2):zraa056. doi: 10.1093/bjsopen/zraa056.
- D'Souza N, Georgiou Delisle T, Chen M, Benton S, Abulafi M; NICE FIT Steering Group. Faecal immunochemical test is superior to symptoms in predicting pathology in patients with suspected colorectal cancer symptoms referred on a 2WW pathway: a diagnostic accuracy study. Gut. 2021 Jun;70(6):1130-1138. doi: 10.1136/gutjnl-2020-321956. Epub 2020 Oct 21.
Datas de registro do estudo
Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.
Datas Principais do Estudo
Início do estudo (Real)
8 de maio de 2026
Conclusão Primária (Estimado)
1 de dezembro de 2026
Conclusão do estudo (Estimado)
1 de dezembro de 2026
Datas de inscrição no estudo
Enviado pela primeira vez
28 de julho de 2026
Enviado pela primeira vez que atendeu aos critérios de CQ
28 de julho de 2026
Primeira postagem (Real)
31 de julho de 2026
Atualizações de registro de estudo
Última Atualização Postada (Real)
31 de julho de 2026
Última atualização enviada que atendeu aos critérios de controle de qualidade
28 de julho de 2026
Última verificação
1 de julho de 2026
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- HSR-FAEX-CRC-FIT-2026
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
NÃO
Descrição do plano IPD
Individual participant data will not be made publicly available or routinely shared with external researchers.
The dataset includes coded clinical information and potentially sensitive stool images, and access is restricted by participant consent, ethics approval, applicable data-protection requirements, and the research data-sharing agreement between Hospital Dr. Sótero del Río and Faex Health.
Study findings will be reported in aggregate and de-identified form.
Any future external secondary use would require separate institutional, ethical, legal, and data-sharing approvals.
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Não
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Não
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .